Amgen says its Ozempic competitor helped patients lose 20% of their weight. Wall Street isn't impressedByBruce GilPublishedNovember 26, 2024UpdatedYesterday
Biden wants to expand access to Ozempic and other popular weight loss drugsByBruce GilPublishedNovember 26, 2024UpdatedYesterday
Elon Musk's Neuralink gets approval to test whether its brain chip can control a robotic armByBruce GilPublishedNovember 25, 2024
More than 72,000 pounds of meat products are being recalled in a deadly, multi-state listeria outbreakByBruce GilPublishedNovember 25, 2024
Streaming was made to escape ads. Now they're back with a vengeanceByBruce GilPublishedNovember 25, 2024
More than 160,000 pounds of ground beef are being recalled nationwide in an E. coli outbreakByBruce GilPublishedNovember 22, 2024
Ozempic 2.0, the Oura ring's new trick, and RFK Jr. vs. vaccines: Pharma news roundupByBruce GilPublishedNovember 22, 2024
Top FDA vaccine official says RFK Jr. nomination is a chance for scientists to make the case for vaccinesByBruce GilPublishedNovember 21, 2024
The first fully robotic double-lung transplant just happened - here's all the detailsByBruce GilPublishedNovember 21, 2024
Weight loss drug makers want more insurance plans to cover Wegovy and ZepboundByBruce GilPublishedNovember 20, 2024
Weight loss drugs are more likely to be covered on government-funded insurance than on private plansByBruce GilUpdatedNovember 18, 2024
Organic carrots are being recalled all over the U.S. in a deadly E. coli outbreakByBruce GilUpdatedNovember 18, 2024
A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drugByBruce GilPublishedNovember 18, 2024
Disney says it's not bailing on traditional TV yet. Its rivals mightByBruce GilPublishedNovember 15, 2024
Amazon and Big Media are discovering that free streaming is a mixed bagByBruce GilPublishedNovember 15, 2024
Amazon is getting into the hair loss and erectile dysfunction businessByBruce GilUpdatedNovember 15, 2024
